Ammash, Omar

Omar N. Ammash

Associate

omar.ammash@lw.com
    Ammash, Omar

    Omar N. Ammash

    Associate

    omar.ammash@lw.com

    Profile

    Omar Ammash represents US and international-based startups, emerging growth companies, and venture capital investors in technology, life sciences, and other growth industries.

    Omar combines extensive experience and a commercial mindset to deliver tailored counsel to emerging companies and investors on a full range of transactions and general corporate matters, including:

    • Venture capital financings
    • Corporate governance
    • Mergers and acquisitions
    • Day-to-day corporate advice
    • Early-stage formation and strategy

    During law school, he was a member of the Corporate Lab, a transactional-focused clinic, working on cutting-edge projects with multinational companies.

    Experience

    Omar’s representative transactions include advising:

    Startup and Emerging Growth Company Financings

    • Oura on its Series D and Series E financings
    • Rivian on multiple venture capital financings
    • Celestial AI on multiple venture capital financings
    • Sleeper on its US$50m Series C financing
    • GT Medical Technologies on its Series C, Series D and Series E financings
    • Novasenta on multiple venture capital financings
    • Crazy Mountain on its US$15 million Series Seed financing 
    • Skyryse on its US$300 million Series C financing
    • Kin Insurance on its US$50 million Series E financing
    • Caris Life Sciences on its US$168 million growth capital funding round
    • LuxWall on its Series B fnancing
    • Iru on its US$100 million funding round
    • Grammarly on its $200 million funding round
    • Homie Technology on multiple venture capital financings
    • Fluid Truck on its Series B financing
    • Jetti Resources on multiple venture capital financings
    • ActiveCampaign on its US$240 million Series C financing
    • Blaize on its US$106 million funding round

    Venture Capital Investments

    • Goldman Sachs on various investments, including in Nested Therapeutics, TORL Biotherapeutics, Ajax Therapeutics, Alterome Therapeutics, and evolvedMD
    • Softbank on various lead investments, including in Forward Health, Sprout Therapy, and M1 Finance
    • Sixth Street in its majority investment in the NWSL’s Bay FC
    • General Catalyst on various investments
    • NVentures on its investment in Charm Therapeutics
    • DNS Capital on various lead investments and follow-on growth financings for its portfolio companies
    • Drive Capital on various lead investments and follow-on growth financings for its portfolio companies
    • GreatPoint Ventures on various lead investments and follow-on growth financings for its portfolio companies
    • Sea Capital on its investment in Forte’s US$725m Series B round
    • Cadence Design Systems on multiple strategic investments

    Mergers, Acquisitions and Capital Markets Transactions

    • Celestial AI on its up to US$5.5 billion acquisition by Marvell
    • Astreya on its acquisition by Cognizant
    • Tegus on its US$1 billion acquisition of Canalyst and its sale to AlphaSense
    • GTCR on its sale of Inteliquent to Sinch
    • Castle Creek on multiple portfolio company acquisitions, including its acquisition of Novavita
    • Henkel on its acquisition of Momentive’s consumer sealants division
    • Blaize on its business combination with BurTech Acquisition Corp.
    • Oscar Health on its US$1.4 billion IPO
    • Aon on its US$80 billion merger of equals with Willis towers (terminated)
    • Carlyle on its acquisition of Apollo Aviation

    Qualifications

    Bar Qualification

    • Illinois

    Education

    • JD, University of Chicago Law School, 2017
    • BA in Political Science, University of Minnesota, 2013
      summa cum laude

    Practices

    Recognition

    News & Insights

    Read More